Hepatic Cancer
Hepatic cancer, or liver cancer, is a type of cancer that begins in the liver cells. It can cause symptoms like weight loss, loss of appetite, and abdominal pain.
We are studying a combination of two medications for children and young adults with newly diagnosed or relapsed solid tumors. The goal is to evaluate safety and how well it may work against specific cancers.
Health conditions and diseases that the clinical trial is designed to study and treat.
Hepatic cancer, or liver cancer, is a type of cancer that begins in the liver cells. It can cause symptoms like weight loss, loss of appetite, and abdominal pain.
Rhabdomyosarcoma is a rare type of cancer that develops in soft tissues, often affecting children. Symptoms may include swelling or a noticeable mass.
Glioma is a type of tumor that occurs in the brain and spinal cord, arising from glial cells. Symptoms can include headaches, seizures, and changes in vision.
Malignant melanoma is a serious form of skin cancer that develops from melanocytes. It can appear as a new or changing mole and may spread to other parts of the body.
Recurrent melanoma refers to melanoma that has returned after treatment. Symptoms may be similar to the original melanoma, including changes in the skin.
Osteosarcoma is a type of bone cancer that typically occurs in the long bones of the arms and legs. Symptoms can include pain and swelling in the affected area.
Classical Hodgkin lymphoma is a type of cancer that affects the lymphatic system. Symptoms may include swollen lymph nodes, fever, and night sweats.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.